Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Recombinant Anti-c-myc epitope tag (Clone 9E10)
| Applications | IF, IHC, IP, WB |
| Conjugation | Unconjugated |
Recombinant Anti-His tag (C-term) (Clone 3D5)
| Applications | ELISA, WB |
| Conjugation | Unconjugated |
Recombinant Anti-Fluorescein (Clone 4-4-20 (enhanced))
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
USD 523.00
2 Weeks
Recombinant Anti-F4/80 (Clone Cl:A3-1 (recombinant version))
| Applications | FC, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD16/CD32 (Clone 2.4G2)
| Applications | FC, IF, IHC, IP |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD52 (Clone Campath-1H)
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-V5 epitope tag (Clone SV5-P-K)
| Applications | ELISA, IF, IHC, IP, WB |
| Conjugation | Unconjugated |
USD 675.00
2 Weeks
Recombinant Anti-CD11b (Clone 5C6 (recombinant version))
| Applications | IF, IHC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Modifications | This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. |
Recombinant Anti-CD2 (Clone YTH 655)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD52 (Clone YTH 34.5-G2b (Campath-1G))
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-CD8 alpha/Lyt-2 (Clone YTS 169.4)
| Applications | FC, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created to reduce immunogenicity during in vivo applications. |
USD 523.00
2 Weeks
Recombinant Anti-Unknown Specificity (Isotype control) (Clone MOPC-21)
| Conjugation | Unconjugated |
| Host | Rat |
| Isotype | IgG2b, kappa |
Recombinant Anti-Complement Receptor 1 & 2 (Clone 7G6)
| Applications | FC, IHC, IP, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD73 (Clone YDBYT 208.3)
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-Human Muscle Acetylcholine Receptor (Clone mAb 192)
| Applications | Bl, ELISA, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-CD8 beta (Clone YTS 156.7.7)
| Applications | FC, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-GITR (Clone YGITR765)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD74 (Clone In-1)
| Applications | FC, IHC, IP |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-MHC II (Clone P7/7)
| Applications | FC, IHC, IP |
| Reactivities | Mouse, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-MHC I (Clone R1-21.2)
| Applications | IHC, IP, R |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD86 (Clone PO.3)
| Applications | Bl, FC, IHC, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD153 (Clone RM153)
| Applications | Bl, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-IL-6R (Clone D7715A7)
| Applications | Bl, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD226 (Clone 10E5)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-IL2R gamma C (Clone 3E12)
| Applications | Bl, FC, IP |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Active filters
Antibody Hosts
- Rat
Isotypes
- IgG2b, kappa
Filter by
Target Symbol
Reactivities
Clonalities
Conjugates
Modifications
- This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (1)
- This is a chimeric antibody created to reduce immunogenicity during in vivo applications. (1)